HEADER TRANSFERASE/TRANSFERASE INHIBITOR 29-AUG-13 4MH7 TITLE CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE TITLE 2 TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC1896 COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE MER; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, UNP RESIDUES 570-864; COMPND 5 SYNONYM: PROTO-ONCOGENE C-MER, RECEPTOR TYROSINE KINASE MERTK; COMPND 6 EC: 2.7.10.1; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: MER, MERTK; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: ROSETTA BL21(DE3)PLYSS; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET28 KEYWDS TYROSINE KINASE, ACUTE LYMPHOBLASTIC LEUKEMIA, RATIONAL STRUCTURE KEYWDS 2 BASED DRUG DESIGN, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR W.ZHANG,A.MCIVER,M.A.STASHKO,D.DERYCKERE,B.R.BRANCHFORD,D.HUNTER, AUTHOR 2 D.B.KIREEV,M.J.MILEY,J.NORRIS-DROUIN,W.M.STEWART,M.LEE,S.SATHER, AUTHOR 3 Y.ZHOU,J.A.DIPAOLA,M.MACHIUS,W.P.JANZEN,H.S.EARP,D.K.GRAHAM,S.FRYE, AUTHOR 4 X.WANG REVDAT 3 20-SEP-23 4MH7 1 REMARK SEQADV LINK REVDAT 2 15-NOV-17 4MH7 1 REMARK REVDAT 1 21-MAY-14 4MH7 0 JRNL AUTH W.ZHANG,A.L.MCIVER,M.A.STASHKO,D.DERYCKERE,B.R.BRANCHFORD, JRNL AUTH 2 D.HUNTER,D.KIREEV,M.J.MILEY,J.NORRIS-DROUIN,W.M.STEWART, JRNL AUTH 3 M.LEE,S.SATHER,Y.ZHOU,J.A.DI PAOLA,M.MACHIUS,W.P.JANZEN, JRNL AUTH 4 H.S.EARP,D.K.GRAHAM,S.V.FRYE,X.WANG JRNL TITL DISCOVERY OF MER SPECIFIC TYROSINE KINASE INHIBITORS FOR THE JRNL TITL 2 TREATMENT AND PREVENTION OF THROMBOSIS. JRNL REF J.MED.CHEM. V. 56 9693 2013 JRNL REFN ISSN 0022-2623 JRNL PMID 24219778 JRNL DOI 10.1021/JM4013888 REMARK 2 REMARK 2 RESOLUTION. 2.51 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: DEV_1468) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.51 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.06 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 83.0 REMARK 3 NUMBER OF REFLECTIONS : 17724 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.279 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1773 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 2.5800 - 2.5100 0.42 0 69 0.2365 0.2864 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : NULL REMARK 3 SOLVENT RADIUS : NULL REMARK 3 SHRINKAGE RADIUS : NULL REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : NULL REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 31.20 REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : 0.025 NULL REMARK 3 PLANARITY : 0.002 NULL REMARK 3 DIHEDRAL : 12.087 NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 4MH7 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 10-SEP-13. REMARK 100 THE DEPOSITION ID IS D_1000081906. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 13-JUN-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 22-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97921 REMARK 200 MONOCHROMATOR : SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 300 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20799 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.510 REMARK 200 RESOLUTION RANGE LOW (A) : 32.060 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.7 REMARK 200 DATA REDUNDANCY : 4.100 REMARK 200 R MERGE (I) : 0.12500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.51 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 81.1 REMARK 200 DATA REDUNDANCY IN SHELL : 3.70 REMARK 200 R MERGE FOR SHELL (I) : 0.56400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.200 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 3BRB REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.26 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.21 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PROTEIN: 32.5 MG/ML IN 20 MM TRIS PH REMARK 280 8.0, 500MM SODIUM CHLORIDE, 2MM BETA-MERCAPTOETHANOL, INCUBATED REMARK 280 WITH INHIBITOR (2.5 MM FINAL CONCENTRATION) OVERNIGHT, MIXED 1:1 REMARK 280 WITH CRYSTALLIZATION SOLUTION (27-33% (V/V) PEG400, 200 MM REMARK 280 MAGNESIUM CHLORIDE, 100 MM TRIS PH 8.5), VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 288K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 45.43200 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 552 REMARK 465 GLY A 553 REMARK 465 SER A 554 REMARK 465 SER A 555 REMARK 465 HIS A 556 REMARK 465 HIS A 557 REMARK 465 HIS A 558 REMARK 465 HIS A 559 REMARK 465 HIS A 560 REMARK 465 HIS A 561 REMARK 465 SER A 562 REMARK 465 SER A 563 REMARK 465 GLY A 564 REMARK 465 LEU A 565 REMARK 465 VAL A 566 REMARK 465 PRO A 567 REMARK 465 ARG A 568 REMARK 465 GLY A 569 REMARK 465 SER A 570 REMARK 465 GLU A 571 REMARK 465 GLU A 572 REMARK 465 LEU A 573 REMARK 465 GLN A 574 REMARK 465 ASN A 575 REMARK 465 LYS A 576 REMARK 465 MET A 621 REMARK 465 LYS A 622 REMARK 465 LEU A 623 REMARK 465 ASP A 624 REMARK 465 ASN A 625 REMARK 465 SER A 626 REMARK 465 SER A 627 REMARK 465 GLN A 628 REMARK 465 ARG A 629 REMARK 465 GLU A 630 REMARK 465 ILE A 631 REMARK 465 GLU A 632 REMARK 465 GLU A 633 REMARK 465 PHE A 634 REMARK 465 LEU A 635 REMARK 465 SER A 636 REMARK 465 GLU A 637 REMARK 465 GLY A 743 REMARK 465 LEU A 744 REMARK 465 SER A 745 REMARK 465 LYS A 746 REMARK 465 LYS A 747 REMARK 465 ILE A 748 REMARK 465 TYR A 749 REMARK 465 SER A 750 REMARK 465 GLY A 751 REMARK 465 ASP A 752 REMARK 465 TYR A 753 REMARK 465 TYR A 754 REMARK 465 ARG A 755 REMARK 465 GLN A 756 REMARK 465 GLY A 757 REMARK 465 ARG A 758 REMARK 465 ILE A 759 REMARK 465 ALA A 760 REMARK 465 LYS A 761 REMARK 465 MET A 762 REMARK 465 PRO A 862 REMARK 465 ASP A 863 REMARK 465 VAL A 864 REMARK 465 MET B 552 REMARK 465 GLY B 553 REMARK 465 SER B 554 REMARK 465 SER B 555 REMARK 465 HIS B 556 REMARK 465 HIS B 557 REMARK 465 HIS B 558 REMARK 465 HIS B 559 REMARK 465 HIS B 560 REMARK 465 HIS B 561 REMARK 465 SER B 562 REMARK 465 SER B 563 REMARK 465 GLY B 564 REMARK 465 LEU B 565 REMARK 465 VAL B 566 REMARK 465 PRO B 567 REMARK 465 ARG B 568 REMARK 465 GLY B 569 REMARK 465 SER B 570 REMARK 465 GLU B 571 REMARK 465 GLU B 572 REMARK 465 LEU B 573 REMARK 465 GLN B 574 REMARK 465 ASN B 575 REMARK 465 LYS B 576 REMARK 465 GLY B 596 REMARK 465 GLU B 597 REMARK 465 PHE B 598 REMARK 465 MET B 659 REMARK 465 SER B 660 REMARK 465 SER B 661 REMARK 465 GLN B 662 REMARK 465 GLY B 663 REMARK 465 ILE B 664 REMARK 465 PRO B 665 REMARK 465 LYS B 666 REMARK 465 GLY B 743 REMARK 465 LEU B 744 REMARK 465 SER B 745 REMARK 465 LYS B 746 REMARK 465 LYS B 747 REMARK 465 ILE B 748 REMARK 465 TYR B 749 REMARK 465 SER B 750 REMARK 465 GLY B 751 REMARK 465 ASP B 752 REMARK 465 TYR B 753 REMARK 465 TYR B 754 REMARK 465 ARG B 755 REMARK 465 GLN B 756 REMARK 465 GLY B 757 REMARK 465 ARG B 758 REMARK 465 ILE B 759 REMARK 465 ALA B 760 REMARK 465 LYS B 761 REMARK 465 MET B 762 REMARK 465 ASP B 863 REMARK 465 VAL B 864 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLU A 597 -118.57 60.84 REMARK 500 PHE A 598 54.58 -98.91 REMARK 500 THR A 690 -45.20 65.92 REMARK 500 ASP A 723 46.01 -164.48 REMARK 500 ASP B 723 45.90 -163.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG A 905 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASN A 728 OD1 REMARK 620 2 ASP A 741 OD2 76.6 REMARK 620 N 1 REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 MG B 905 MG REMARK 620 N RES CSSEQI ATOM REMARK 620 1 GLU A 823 OE1 REMARK 620 2 GLU A 823 OE2 44.9 REMARK 620 3 SER B 686 O 110.8 97.4 REMARK 620 4 LEU B 688 O 73.2 118.1 102.7 REMARK 620 5 PRO B 692 O 153.9 121.5 91.6 115.8 REMARK 620 N 1 2 3 4 REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL A 904 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC4 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG A 905 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC5 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MH7 A 906 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC6 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC7 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 902 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC8 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CL B 903 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC9 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE MG B 905 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2POC RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE REMARK 900 TYROSINE-PROTEIN KINASE MER REMARK 900 RELATED ID: 3TCP RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE REMARK 900 TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC569 REMARK 900 RELATED ID: 2BRB RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE REMARK 900 TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH ADP REMARK 900 RELATED ID: 3BPR RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE REMARK 900 TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR C52 REMARK 900 RELATED ID: 4M3Q RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE CATALYTIC DOMAIN OF THE PROTO-ONCOGENE REMARK 900 TYROSINE-PROTEIN KINASE MER IN COMPLEX WITH INHIBITOR UNC1917 REMARK 900 RELATED ID: 4MHA RELATED DB: PDB DBREF 4MH7 A 570 864 UNP Q12866 MERTK_HUMAN 570 864 DBREF 4MH7 B 570 864 UNP Q12866 MERTK_HUMAN 570 864 SEQADV 4MH7 MET A 552 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 GLY A 553 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 SER A 554 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 SER A 555 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 HIS A 556 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 HIS A 557 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 HIS A 558 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 HIS A 559 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 HIS A 560 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 HIS A 561 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 SER A 562 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 SER A 563 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 GLY A 564 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 LEU A 565 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 VAL A 566 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 PRO A 567 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 ARG A 568 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 GLY A 569 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 MET B 552 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 GLY B 553 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 SER B 554 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 SER B 555 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 HIS B 556 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 HIS B 557 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 HIS B 558 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 HIS B 559 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 HIS B 560 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 HIS B 561 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 SER B 562 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 SER B 563 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 GLY B 564 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 LEU B 565 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 VAL B 566 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 PRO B 567 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 ARG B 568 UNP Q12866 EXPRESSION TAG SEQADV 4MH7 GLY B 569 UNP Q12866 EXPRESSION TAG SEQRES 1 A 313 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 313 LEU VAL PRO ARG GLY SER GLU GLU LEU GLN ASN LYS LEU SEQRES 3 A 313 GLU ASP VAL VAL ILE ASP ARG ASN LEU LEU ILE LEU GLY SEQRES 4 A 313 LYS ILE LEU GLY GLU GLY GLU PHE GLY SER VAL MET GLU SEQRES 5 A 313 GLY ASN LEU LYS GLN GLU ASP GLY THR SER LEU LYS VAL SEQRES 6 A 313 ALA VAL LYS THR MET LYS LEU ASP ASN SER SER GLN ARG SEQRES 7 A 313 GLU ILE GLU GLU PHE LEU SER GLU ALA ALA CYS MET LYS SEQRES 8 A 313 ASP PHE SER HIS PRO ASN VAL ILE ARG LEU LEU GLY VAL SEQRES 9 A 313 CYS ILE GLU MET SER SER GLN GLY ILE PRO LYS PRO MET SEQRES 10 A 313 VAL ILE LEU PRO PHE MET LYS TYR GLY ASP LEU HIS THR SEQRES 11 A 313 TYR LEU LEU TYR SER ARG LEU GLU THR GLY PRO LYS HIS SEQRES 12 A 313 ILE PRO LEU GLN THR LEU LEU LYS PHE MET VAL ASP ILE SEQRES 13 A 313 ALA LEU GLY MET GLU TYR LEU SER ASN ARG ASN PHE LEU SEQRES 14 A 313 HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU ARG ASP SEQRES 15 A 313 ASP MET THR VAL CYS VAL ALA ASP PHE GLY LEU SER LYS SEQRES 16 A 313 LYS ILE TYR SER GLY ASP TYR TYR ARG GLN GLY ARG ILE SEQRES 17 A 313 ALA LYS MET PRO VAL LYS TRP ILE ALA ILE GLU SER LEU SEQRES 18 A 313 ALA ASP ARG VAL TYR THR SER LYS SER ASP VAL TRP ALA SEQRES 19 A 313 PHE GLY VAL THR MET TRP GLU ILE ALA THR ARG GLY MET SEQRES 20 A 313 THR PRO TYR PRO GLY VAL GLN ASN HIS GLU MET TYR ASP SEQRES 21 A 313 TYR LEU LEU HIS GLY HIS ARG LEU LYS GLN PRO GLU ASP SEQRES 22 A 313 CYS LEU ASP GLU LEU TYR GLU ILE MET TYR SER CYS TRP SEQRES 23 A 313 ARG THR ASP PRO LEU ASP ARG PRO THR PHE SER VAL LEU SEQRES 24 A 313 ARG LEU GLN LEU GLU LYS LEU LEU GLU SER LEU PRO ASP SEQRES 25 A 313 VAL SEQRES 1 B 313 MET GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 313 LEU VAL PRO ARG GLY SER GLU GLU LEU GLN ASN LYS LEU SEQRES 3 B 313 GLU ASP VAL VAL ILE ASP ARG ASN LEU LEU ILE LEU GLY SEQRES 4 B 313 LYS ILE LEU GLY GLU GLY GLU PHE GLY SER VAL MET GLU SEQRES 5 B 313 GLY ASN LEU LYS GLN GLU ASP GLY THR SER LEU LYS VAL SEQRES 6 B 313 ALA VAL LYS THR MET LYS LEU ASP ASN SER SER GLN ARG SEQRES 7 B 313 GLU ILE GLU GLU PHE LEU SER GLU ALA ALA CYS MET LYS SEQRES 8 B 313 ASP PHE SER HIS PRO ASN VAL ILE ARG LEU LEU GLY VAL SEQRES 9 B 313 CYS ILE GLU MET SER SER GLN GLY ILE PRO LYS PRO MET SEQRES 10 B 313 VAL ILE LEU PRO PHE MET LYS TYR GLY ASP LEU HIS THR SEQRES 11 B 313 TYR LEU LEU TYR SER ARG LEU GLU THR GLY PRO LYS HIS SEQRES 12 B 313 ILE PRO LEU GLN THR LEU LEU LYS PHE MET VAL ASP ILE SEQRES 13 B 313 ALA LEU GLY MET GLU TYR LEU SER ASN ARG ASN PHE LEU SEQRES 14 B 313 HIS ARG ASP LEU ALA ALA ARG ASN CYS MET LEU ARG ASP SEQRES 15 B 313 ASP MET THR VAL CYS VAL ALA ASP PHE GLY LEU SER LYS SEQRES 16 B 313 LYS ILE TYR SER GLY ASP TYR TYR ARG GLN GLY ARG ILE SEQRES 17 B 313 ALA LYS MET PRO VAL LYS TRP ILE ALA ILE GLU SER LEU SEQRES 18 B 313 ALA ASP ARG VAL TYR THR SER LYS SER ASP VAL TRP ALA SEQRES 19 B 313 PHE GLY VAL THR MET TRP GLU ILE ALA THR ARG GLY MET SEQRES 20 B 313 THR PRO TYR PRO GLY VAL GLN ASN HIS GLU MET TYR ASP SEQRES 21 B 313 TYR LEU LEU HIS GLY HIS ARG LEU LYS GLN PRO GLU ASP SEQRES 22 B 313 CYS LEU ASP GLU LEU TYR GLU ILE MET TYR SER CYS TRP SEQRES 23 B 313 ARG THR ASP PRO LEU ASP ARG PRO THR PHE SER VAL LEU SEQRES 24 B 313 ARG LEU GLN LEU GLU LYS LEU LEU GLU SER LEU PRO ASP SEQRES 25 B 313 VAL HET CL A 901 1 HET CL A 902 1 HET CL A 903 1 HET CL A 904 1 HET MG A 905 1 HET MH7 A 906 62 HET CL B 901 1 HET CL B 902 1 HET CL B 903 1 HET CL B 904 1 HET MG B 905 1 HETNAM CL CHLORIDE ION HETNAM MG MAGNESIUM ION HETNAM MH7 N-BUTYL-2-(BUTYLAMINO)-4-[(TRANS-4-HYDROXYCYCLOHEXYL) HETNAM 2 MH7 AMINO]-N-METHYLPYRIMIDINE-5-CARBOXAMIDE FORMUL 3 CL 8(CL 1-) FORMUL 7 MG 2(MG 2+) FORMUL 8 MH7 C20 H35 N5 O2 FORMUL 14 HOH *29(H2 O) HELIX 1 1 ASP A 583 ASN A 585 5 3 HELIX 2 2 ALA A 639 PHE A 644 1 6 HELIX 3 3 ASP A 678 SER A 686 1 9 HELIX 4 4 PRO A 696 ARG A 717 1 22 HELIX 5 5 ALA A 725 ARG A 727 5 3 HELIX 6 6 PRO A 763 ILE A 767 5 5 HELIX 7 7 ALA A 768 ASP A 774 1 7 HELIX 8 8 THR A 778 THR A 795 1 18 HELIX 9 9 GLN A 805 HIS A 807 5 3 HELIX 10 10 GLU A 808 HIS A 815 1 8 HELIX 11 11 LEU A 826 SER A 835 1 10 HELIX 12 12 CYS A 836 ARG A 838 5 3 HELIX 13 13 ASP A 840 ARG A 844 5 5 HELIX 14 14 THR A 846 SER A 860 1 15 HELIX 15 15 ASP B 583 ASN B 585 5 3 HELIX 16 16 GLN B 628 PHE B 644 1 17 HELIX 17 17 ASP B 678 ARG B 687 1 10 HELIX 18 18 PRO B 696 ARG B 717 1 22 HELIX 19 19 ALA B 725 ARG B 727 5 3 HELIX 20 20 PRO B 763 ILE B 767 5 5 HELIX 21 21 ALA B 768 ASP B 774 1 7 HELIX 22 22 THR B 778 THR B 795 1 18 HELIX 23 23 GLN B 805 HIS B 807 5 3 HELIX 24 24 GLU B 808 HIS B 815 1 8 HELIX 25 25 LEU B 826 SER B 835 1 10 HELIX 26 26 CYS B 836 ARG B 838 5 3 HELIX 27 27 ASP B 840 ARG B 844 5 5 HELIX 28 28 THR B 846 SER B 860 1 15 SHEET 1 A 5 LEU A 587 GLU A 595 0 SHEET 2 A 5 SER A 600 LYS A 607 -1 O VAL A 601 N GLY A 594 SHEET 3 A 5 SER A 613 LYS A 619 -1 O VAL A 618 N MET A 602 SHEET 4 A 5 PRO A 665 PRO A 672 -1 O LEU A 671 N ALA A 617 SHEET 5 A 5 GLY A 654 MET A 659 -1 N CYS A 656 O MET A 668 SHEET 1 B 2 CYS A 729 LEU A 731 0 SHEET 2 B 2 VAL A 737 VAL A 739 -1 O CYS A 738 N MET A 730 SHEET 1 C 5 LEU B 587 GLY B 594 0 SHEET 2 C 5 SER B 600 LYS B 607 -1 O VAL B 601 N LEU B 593 SHEET 3 C 5 SER B 613 THR B 620 -1 O VAL B 618 N MET B 602 SHEET 4 C 5 MET B 668 PRO B 672 -1 O LEU B 671 N ALA B 617 SHEET 5 C 5 GLY B 654 CYS B 656 -1 N GLY B 654 O ILE B 670 SHEET 1 D 2 CYS B 729 LEU B 731 0 SHEET 2 D 2 VAL B 737 VAL B 739 -1 O CYS B 738 N MET B 730 LINK OD1 ASN A 728 MG MG A 905 1555 1555 2.65 LINK OD2 ASP A 741 MG MG A 905 1555 1555 2.01 LINK OE1 GLU A 823 MG MG B 905 1555 1555 2.83 LINK OE2 GLU A 823 MG MG B 905 1555 1555 2.91 LINK O SER B 686 MG MG B 905 1555 1555 2.46 LINK O LEU B 688 MG MG B 905 1555 1555 2.32 LINK O PRO B 692 MG MG B 905 1555 1555 2.13 SITE 1 AC1 2 PRO A 802 LYS A 820 SITE 1 AC2 1 HOH B1014 SITE 1 AC3 2 ARG A 584 LEU A 589 SITE 1 AC4 3 ASN A 728 ASP A 741 MH7 A 906 SITE 1 AC5 10 GLY A 594 GLU A 595 ALA A 617 ILE A 650 SITE 2 AC5 10 PRO A 672 PHE A 673 MET A 674 LYS A 675 SITE 3 AC5 10 ALA A 740 MG A 905 SITE 1 AC6 2 ARG B 651 ARG B 732 SITE 1 AC7 3 LEU A 688 PRO B 802 LYS B 820 SITE 1 AC8 2 ARG B 584 LEU B 589 SITE 1 AC9 5 GLU A 823 SER B 686 LEU B 688 GLY B 691 SITE 2 AC9 5 PRO B 692 CRYST1 50.874 90.864 69.587 90.00 99.98 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.019656 0.000000 0.003460 0.00000 SCALE2 0.000000 0.011005 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014591 0.00000